Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Wednesday, November 26 2014 6:12pm ET - U.S. Markets Closed.
Industry Center
Industry Center > > MedImmune, L.L.C. Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
MedImmune, L.L.C. Company Profile
MedImmune works to boost the immune systems of babies and grown-ups. Its flagship biotech product, Synagis, prevents respiratory syncytial virus (RSV), a major cause of pneumonia and other respiratory disease in infants and children. Also on the market are FluMist, its nasal spray flu vaccine, and Ethyol (amifostine), which treats side effects of chemotherapy and radiation. The company is working on dozens of investigational therapies -- including monoclonal antibodies, vaccines, and small molecule drugs -- in the areas of infectious disease, cancer, inflammation, and autoimmune and respiratory conditions. MedImmune is a subsidiary of UK-based pharmaceutical giant AstraZeneca.
Headlines for MedImmune, L.L.C.
AstraZeneca lupus drug produces positive results in trial
- Mon Nov 17
AstraZeneca developing reversal agent for heart drug Brilinta
- Thu Nov 13
AstraZeneca strengthens cancer business with new deals
- Tue Nov 4
AstraZeneca buys pioneering data-analysis firm Definiens
- Tue Nov 4
Inovio-Roche End Deal for Development of Cancer Therapy
- Tue Nov 18
AstraZeneca Sells Myalept to Aegerion for $325 Million Upfront
- Thu Nov 6
Contact Information
Address: 1 MedImmune Way
Gaithersburg, MD 20878
Phone:301-398-0000
Fax:
Key People
Chief Operations Officer: Matt Bell
Chief Financial Officer: Tim Gray
EVP Commercial Operations: Scott P. Carmer
Industry Information
Sector:
Industry:
Top Competitors
Amgen Inc. (amgn)
Merck & Co., Inc. (mrk)
Roche Holding Ltd (rhhby)
 


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?